Minnesota’s medical marijuana market could be smaller than expected, as patients will reportedly have to shell out between $100 and $500 a month for medicine.
The two companies designated by the state government to sell cannabis-infused products have pledged to “set up special pricing structures” for lower-income patients, the Associated Press reported.
But even so, average costs could deter patients from signing up for the program, or push them toward the black market.
One of the licensed companies, Minnesota Medical Solutions (MinnMed), said a patient can expect to pay between $100 and $500 a month for its products, while the other, LeafLine, will likely offer a month’s supply of cannabis-based medicine for between $250 and $500, according to the AP.
The high pricetags are a direct result of state regulations that prohibit smokeable marijuana and require cannabis to be converted into pills, oils or vapors. Also adding to the cost are tight security requirements, along with transportation costs from production facilities to dispensaries.
MinnMed said it is planning on instituting a pricing scale based on income to aid patients with lower incomes. Those below the federal poverty level can qualify for up to 60% off, and those who make up to double the federal poverty level can get up to 30% off.
LeafLine, meanwhile, is still trying to figure out how to lower its prices for low-income patients in need.
Minnesota dispensaries are slated to open starting July 1.